Elevated Troponins and Diagnosis of Non-ST-Elevation Myocardial Infarction in the Emergency Department

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 5; p. e59910
• Main Authors: Ali, Farman, Arshad, Khurram, Szpunar, Susan, Daher, Edouard
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 08.05.2024; Cureus
• Subjects: Acute coronary syndromes; Blood tests; Cardiac catheterization; Cardiac stress tests; Cardiology; Cardiovascular disease; Coronary vessels; Diabetes; Emergency medical care; Emergency Medicine; Heart attacks; Heart failure; Hospitals; Hyperlipidemia; Hypertension; Internal Medicine; Intubation; Ischemia; Kidney diseases; Medical diagnosis; Medical imaging; Pain; Sepsis; Smoking; Ultrasonic imaging; Vein & artery diseases; United States > US; acute coronary syndrome (acs); non-st-segment elevation myocardial infarction (nstemi); 2d echocardiography; troponin; emergency department; cardiac troponin
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.59910

Background In the emergency department (ED), the diagnosis of non-ST-elevation myocardial infarction (NSTEMI) is primarily based on the presence or absence of elevated cardiac troponin levels, ECG changes, and clinical presentation. However, limited data exist regarding the incidence, clinical characteristics, and predictive value of different cardiac diagnostic tests and outcomes in patients with non-acute coronary syndrome (ACS)-related troponin elevation. Our study aimed to determine the percentage of patients with elevated troponin levels who had true ACS and identify various risk factors associated with true ACS in these patients. Methodology This was a single-center retrospective study. We performed a chart review of patients who presented to the ED from January 1, 2016, to December 31, 2017, and were admitted to the hospital with an elevated cardiac troponin I level in the first 12 hours after ED presentation with a diagnosis of NSTEMI. True ACS was defined as (a) patients with typical symptoms of ischemia and ECG ischemic changes and (b) patients with atypical symptoms of myocardial ischemia or without symptoms of ischemia and new segmental wall motion abnormalities on echocardiogram or evidence of culprit lesion on angiography. A logistic regression model was used to determine the association between risk factors and true ACS. Results A total of 204 patients were included in this study. The mean age of the study group was 67.4 ± 14.5 years; 53.4% (n = 109) were male, and 57.4% (n = 117) were Caucasian. In our study, 51% of patients were found to have true ACS, and the remaining 49% had a non-ACS-related elevation in troponins. Most patients without ACS had alternate explanations for elevated troponin levels. The presence of chest pain (odds ratio (OR) = 3.7, 95% confidence interval (CI) = 1.8-7.7, p = 0.001), tobacco smoking (OR = 4, 95% CI = 1.06-3.8, p = 0.032), and wall motion abnormalities on echocardiogram (OR = 3.8, 95% CI = 1.8-6.5, p = 001) were associated with increased risk of true ACS in patients with elevated troponins. Conclusions Cardiac troponin levels can be elevated in hospitalized patients with various medical conditions, in the absence of ACS. The diagnosis of ACS should not be solely based on elevated troponin levels, as it can lead to expensive workup and utilization of hospital resources.